Subscribe To
ERYP / Why Is Erytech Pharma (ERYP) Stock Up 47% Today?
ERYP News
By Seeking Alpha
May 13, 2023
Erytech Pharma SA (ERYP) Q1 2023 Earnings Call Transcript
Erytech Pharma SA (NASDAQ:ERYP ) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Gil Beyen - CEO Thibaut du Fayet - CEO, more_horizontal
By InvestorPlace
May 9, 2023
Why Is Erytech Pharma (ERYP) Stock Up 47% Today?
Erytech Pharma (NASDAQ: ERYP ) stock is on the rise Tuesday after the company provided investors with a business update for Q1! First up is the compan more_horizontal
By Zacks Investment Research
August 26, 2022
Erytech (ERYP) Stops Developing Drug in Leukemia, Down 19.6%
After evaluating the FDA's feedback, Erytech Pharma (ERYP) halts developing its lead candidate in leukemia. It is also looking for strategic partnersh more_horizontal
By Seeking Alpha
May 13, 2022
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2022 Results - Earnings Call Transcript
ERYTECH Pharma S.A. (NASDAQ:ERYP ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Gil Beyen – Chief Executive Officer more_horizontal
By Benzinga
April 25, 2022
Why Erytech Pharma Are Shares Moving Higher Today
Erytech Pharma SA (NASDAQ: ERYP) has sold its US manufacturing facility to Catalent Inc (NYSE: CTLT) for $44.5 million. Catalent will acquire Eryt more_horizontal
By Benzinga
April 7, 2022
Why Erytech Pharma Shares Are Rising Today
Erytech Pharma SA (NASDAQ: ERYP) says that the results from the NOPHO sponsored Phase 2 trial of eryaspase in acute lymphoblastic leukemia (ALL) pati more_horizontal
By Seeking Alpha
March 14, 2022
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript more_horizontal